|
Real-time Estimate
Cboe BZX
11:18:06 27/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 548.47 USD | +0.22% |
|
+1.81% | +21.33% |
| 12/08 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 11/08 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14TCr | |||||
| 1,06000Cr | |||||
| 65TCr | - | - | - | ||
| 46TCr | |||||
| 37TCr | |||||
| 30TCr |
Select your edition
All financial news and data tailored to specific country editions
